DHR · Danaher Corp /De/
$200.04
+0.38 (+0.19%)
At close · Aug 6
Market Cap
$140.58B
Shares
702.99M
Danaher Corp Earnings Call Transcripts
Every quarterly earnings call for Danaher Corp (DHR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼10.7%
$6.46B
$1.57B
'22 Q3
22-10-20
▲104%
$7.13B
$2.23B
'22 Q4
23-01-09
▼8.8%
$5.95B
$1.45B
'23 Q1
23-04-25
▼9.4%
$5.91B
$1.11B
'23 Q2
23-07-25
▼12.9%
$5.62B
$1.13B
'23 Q3
23-10-24
▼10.2%
$6.41B
$1.08B
'23 Q4
24-01-30
▼2.6%
$5.80B
$1.09B
'24 Q1
24-04-23
▼2.9%
$5.74B
$907.00M
'24 Q2
24-07-23
▲3.1%
$5.80B
$818.00M
'24 Q3
24-10-22
▲2.1%
$6.54B
$1.09B
'24 Q4
25-01-13
▼0.9%
$5.74B
$954.00M
'25 Q1
25-04-22
▲3.4%
$5.94B
$555.00M
'25 Q2
25-07-22
▲4.4%
$6.05B
$908.00M
'25 Q3
25-10-21
▲4.6%
$6.84B
$1.20B
'25 Q4
26-01-28
▲3.7%
$5.95B
$1.03B
'26 Q1
26-04-21
LATEST
▲5.5%
$6.26B
$870.00M
'26 Q2
26-07-21
Earnings call
FY26 · Q2
2026-07-21
Danaher Corp /De/ Q2 FY2026 Earnings Call
Positive tone
Bioprocessing shipment delays and rebase
Order book strength and reshoring
Customer demand and end-market commentary
Revenue
$6.26B
▲ 5.5% YoY Diluted EPS
$1.23
▲ 59.7% YoY Gross margin
57.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-21
Danaher Corp /De/ Q1 FY2026 Earnings Call
Positive tone
Masimo acquisition and capital deployment
Respiratory weakness at Cepheid
China end markets
Revenue
$5.95B
▲ 3.7% YoY Diluted EPS
$1.45
▲ 9.8% YoY Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-28
Danaher Corp /De/ Q4 FY2025 Earnings Call
Positive tone
Bioprocessing momentum
Pharma R&D and capital spending recovery
Academic and government softness
Revenue
$6.84B*
▲ 4.6% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-21
Danaher Corp /De/ Q3 FY2025 Earnings Call
Positive tone
China market headwinds and localization
Bioprocessing / monoclonal antibodies demand
Innovation and product launches
Revenue
$6.05B
▲ 4.4% YoY Diluted EPS
$1.27
▲ 13.4% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-22
Danaher Corp /De/ Q2 FY2025 Earnings Call
Balanced tone
Bioprocessing / Biotech Performance
China and Geographies
Diagnostics / Cepheid Respiratory and Non-Respiratory
Revenue
$5.94B
▲ 3.4% YoY Diluted EPS
$0.77
▼ 36.9% YoY Gross margin
59.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-22
Danaher Corp /De/ Q1 FY2025 Earnings Call
Positive tone
China and volume-based procurement
Bioprocessing momentum
Macro and trade uncertainty
Revenue
$5.74B
▼ 0.9% YoY Diluted EPS
$1.32
▼ 9% YoY Gross margin
61.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-13
Danaher Corp /De/ Q4 FY2024 Earnings Call
Positive tone
Bioprocessing recovery and momentum
Diagnostics and respiratory season
China headwinds
Revenue
$6.54B*
▲ 2.1% YoY Gross margin
59.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-22
Danaher Corp /De/ Q3 FY2024 Earnings Call
Positive tone
China weakness and stimulus uncertainty
Bioprocessing recovery
2025 outlook and DBS savings
Revenue
$5.80B
▲ 3.1% YoY Diluted EPS
$1.12
▼ 25.8% YoY Gross margin
58.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-23
Danaher Corp /De/ Q2 FY2024 Earnings Call
Positive tone
Bioprocessing recovery
China weakness and stimulus
Diagnostics and Cepheid
Revenue
$5.74B
▼ 2.9% YoY Diluted EPS
$1.22
▼ 18.1% YoY Gross margin
59.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-23
Danaher Corp /De/ Q1 FY2024 Earnings Call
Confident tone
Bioprocessing recovery
M&A and capital deployment
Large pharma demand
Revenue
$5.80B
▼ 2.6% YoY Diluted EPS
$1.45
▼ 25.3% YoY Gross margin
60.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-30
Danaher Corp /De/ Q4 FY2023 Earnings Call
Balanced tone
2024 guidance and outlook
Bioprocessing destocking and recovery
Diagnostics and Cepheid respiratory
Revenue
$6.41B
▼ 10.2% YoY Diluted EPS
$1.45
▼ 51.5% YoY Gross margin
59.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-24
Danaher Corp /De/ Q3 FY2023 Earnings Call
Revenue
$5.62B
▼ 12.9% YoY Diluted EPS
$1.51
▼ 28.1% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-25
Danaher Corp /De/ Q2 FY2023 Earnings Call
Revenue
$5.91B
▼ 9.4% YoY Diluted EPS
$1.49
▼ 33.8% YoY Gross margin
56.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
Danaher Corp /De/ Q1 FY2023 Earnings Call
Revenue
$5.95B
▼ 8.8% YoY Diluted EPS
$1.94
▼ 16% YoY Gross margin
61.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Danaher Corp /De/ Q4 FY2022 Earnings Call
Revenue
$7.13B
▲ 104% YoY Diluted EPS
$2.99
Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-20
Danaher Corp /De/ Q3 FY2022 Earnings Call
Revenue
$6.46B
▼ 10.7% YoY Diluted EPS
$2.10
▲ 53.8% YoY Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-21
Danaher Corp /De/ Q2 FY2022 Earnings Call
Revenue
$6.53B
▼ 9.6% YoY Diluted EPS
$2.25
▲ 5.8% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-21
Danaher Corp /De/ Q1 FY2022 Earnings Call
Revenue
$6.53B
▼ 4.8% YoY Diluted EPS
$2.31
▲ 13.8% YoY Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-27
Danaher Corp /De/ Q4 FY2021 Earnings Call
Revenue
$3.50B*
▼ 48.3% YoY Gross margin
63.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-21
Danaher Corp /De/ Q3 FY2021 Earnings Call
Revenue
$7.23B
▲ 22.9% YoY Diluted EPS
$1.37
▲ 32.8% YoY Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-22
Danaher Corp /De/ Q2 FY2021 Earnings Call
Revenue
$7.22B
▲ 36.3% YoY Diluted EPS
$2.13
▲ 93.5% YoY Gross margin
60.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-22
Danaher Corp /De/ Q1 FY2021 Earnings Call
Revenue
$6.86B
▲ 57.9% YoY Diluted EPS
$2.03
▲ 182.7% YoY Gross margin
62.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-13
Danaher Corp /De/ Q4 FY2020 Earnings Call
Revenue
$6.76B*
▲ 38.9% YoY Gross margin
58.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-22
Danaher Corp /De/ Q3 FY2020 Earnings Call
Revenue
$5.88B
▲ 34.4% YoY Diluted EPS
$1.03
▲ 30.3% YoY Gross margin
54.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
Danaher Corp /De/ Q2 FY2020 Earnings Call
Revenue
$5.30B
▲ 19.2% YoY Diluted EPS
$1.10
▲ 27.8% YoY Gross margin
53.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-13
Danaher Corp /De/ Q1 FY2020 Earnings Call
Revenue
$4.34B
▲ 2.9% YoY Diluted EPS
$0.72
▲ 76.1% YoY Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-13
Danaher Corp /De/ Q4 FY2019 Earnings Call
Revenue
$4.87B
▼ 9.2% YoY Diluted EPS
$1.53
▲ 64.8% YoY Gross margin
55.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
313616
CUSIP
235851102
13F (30d)
1113 filings
1073 filers
Visit website
Investor relations